NCT02862353View on ClinicalTrials.gov

Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Thrombocytopenia
Interventions
BIOLOGICAL

blood sample

15 ml of blood

Trial Locations (1)

42055

CHU de Saint Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02862353 - Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic | Biotech Hunter | Biotech Hunter